Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Global Lyme Alliance Awards $2 Million in Scientific Research Grants for 2019

GLA's Lyme disease research initiatives range from diagnosing pediatric Lyme disease, new treatment protocols, to evaluating Lyme and suicide risks


News provided by

Global Lyme Alliance

Jun 04, 2019, 05:15 ET

Share this article

Share toX

Share this article

Share toX


STAMFORD, Conn., June 4, 2019 /PRNewswire-PRWeb/ -- Global Lyme Alliance (GLA), the leading 501 (c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education and awareness, today announced that it has awarded $2 million for new research grants and related projects to researchers at top-tier universities and medical institutions in the U.S. and abroad. This includes underwriting the largest population study ever to examine psychiatric disorders and suicide linked to Lyme disease.

"Our new grantees span a broad spectrum of research interests in the tick-borne disease field," said Scott Santarella, GLA's CEO, "and are especially exciting in terms of their scientific breadth and depth. Our ongoing investment in the most promising scientific research is helping us to accelerate the pace of new diagnostic and therapeutic developments to benefit Lyme patients."

"Our ongoing investment in the most promising scientific research is helping us to accelerate the pace of new diagnostic and therapeutic developments to benefit Lyme patients."

Post this

In announcing the new grants, Santarella noted that the total amount requested was the highest in GLA's history—more than $8 million, a 200% increase in funding requests from the previous year. "We were pleased to see such a strong interest in Lyme disease among researchers," he said. "It underscores the fact that the need for financial support is greater than ever before."

Lyme is the fastest-growing vector-borne disease in the nation, yet "federal funding for tick-borne disease research is woefully inadequate compared to funding for many other diseases," said Timothy J. Sellati, Ph.D., GLA's Chief Scientific Officer. Despite the fact that over the past 25 years Lyme infections have increased substantially, only $30 million was allocated in 2018 for Lyme research by the National Institutes of Health. This for a disease which newly infects 427,000 individuals in the U.S. each year, compared with $36 million for mosquito-transmitted West Nile Virus, which affected about 2,500 in the U.S. in 2018 and $129 million for Hepatitis C, which affected 104,000 in the U.S. last year.

GLA's grant recipients include:

  • Sheila Arvikar, M.D., Harvard Medical School, "Musculoskeletal Ultrasound Evaluation of Tendon Involvement in Lyme Disease."

  • Michael Eriksen Benros, M.D. Ph.D., Mental Health Center, Copenhagen University Hospital, "Nationwide Cohort Studies Examining Psychiatric Disorders and Suicidal Behavior after Lyme Disease."

  • Lise Nigrovic, M.D., M.P.H., Boston Children's Hospital, Harvard Medical School, "Novel Approaches to the Diagnosis of Lyme Disease and Other Tick-borne Co-infections in Children."

  • Benjamin Readhead, Ph.D., Arizona State University, "An Interesting Necroptosis Angle: Tickborne Disease and Alzheimer's Disease."

  • Rafal Tokarz, Ph.D., Columbia University, "Development and Validation of a Multiplex Serologic Assay for Tick-borne Diseases."

  • Ying Zhang, M.D., Ph.D., Johns Hopkins Bloomberg School of Public Health, "High Activity of Selective Essential Oils Against Borrelia Persisters."

All of GLA's projects are focused on helping patients. Among the projects funded is the organization's first-ever study in Denmark, a country that tracks all residents in demographic and health databases. One of the largest studies of its kind, it aims to use information on everyone born after 1977 (~2.44 million people) to evaluate whether Lyme disease is a risk factor for mental disorders, particularly depression and suicide.

Another research project being conducted at Boston Children's Hospital will support a pediatric biobank to collect patient samples and clinical data drawn from seven hospitals in seven Lyme-endemic states. This repository is a valuable resource for the development of new diagnostic tests and for understanding pediatric infection since patient DNA, mRNA and blood can be analyzed and correlated with patients' clinical presentation.

Moreover, GLA's support also includes continued funding for research efforts from the last 18 months, as well as funding for the Blackman-GLA Postdoctoral Fellowships Program. GLA has also started investing in clinical studies to accelerate patient impact.

GLA's rigorous process for evaluating grant applications, unique among Lyme disease nonprofits, is modeled on the peer-review guidelines of the National Institutes of Health. Our Scientific Advisory Board (SAB) members, comprised of scientists in industry and academia who are all noted experts in medical research, immunology, and microbiology evaluate applications in their respective fields. Each application is then reviewed according to strict criteria, followed by a series of discussions to ensure that only the most promising applications are funded. Applications for the 2020 grants period will be accepted shortly.

ABOUT GLOBAL LYME ALLIANCE Global Lyme Alliance is the leading 501(c)(3) dedicated to conquering Lyme and other tick-borne diseases through research, education, and awareness. GLA has gained national prominence for funding some of the most urgent and promising research in the world, while expanding education and awareness programs for the general public and physicians. We support those around the globe needing information about tick-borne diseases. Learn more at http://GLA.org.

SOURCE Global Lyme Alliance

Related Links

http://GLA.org

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.